Intermediate filaments in disease.

[1]  C. Babinet,et al.  Mice lacking vimentin develop and reproduce without an obvious phenotype , 1994, Cell.

[2]  E. Fuchs,et al.  A human keratin 14 "knockout": the absence of K14 leads to severe epidermolysis bullosa simplex and a function for an intermediate filament protein. , 1994, Genes & development.

[3]  E. Lane,et al.  A functional "knockout" of human keratin 14. , 1994, Genes & development.

[4]  P. Fritsch,et al.  Mutations of keratin 9 in two families with palmoplantar epidermolytic hyperkeratosis. , 1994, The Journal of investigative dermatology.

[5]  E. Lane,et al.  Ichthyosis bullosa of Siemens is caused by mutations in the keratin 2e gene. , 1994, The Journal of investigative dermatology.

[6]  E. Lane,et al.  Ichthyosis bullosa of Siemens--a disease involving keratin 2e. , 1994, The Journal of investigative dermatology.

[7]  T. Strachan,et al.  A gene for pachyonychia congenita is closely linked to the keratin gene cluster on 17q12-q21. , 1994, Journal of medical genetics.

[8]  D. Hohl,et al.  Mutations in the rod domain of keratin 2e in patients with ichthyosis bullosa of Siemens , 1994, Nature Genetics.

[9]  E. Fuchs,et al.  Genetic mutations in the K1 and K10 genes of patients with epidermolytic hyperkeratosis. Correlation between location and disease severity. , 1994, The Journal of clinical investigation.

[10]  R. Kucherlapati,et al.  Mutations in the non-helical linker segment L1-2 of keratin 5 in patients with Weber-Cockayne epidermolysis bullosa simplex. , 1994, Journal of cell science.

[11]  S. Bale,et al.  Preferential sites in keratin 10 that are mutated in epidermolytic hyperkeratosis. , 1994, American journal of human genetics.

[12]  A. Peterson,et al.  Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-β-galactosidase fusion protein , 1994, Neuron.

[13]  Karl Sperling,et al.  Keratin 9 gene mutations in epidermolytic palmoplantar keratoderma (EPPK) , 1994, Nature Genetics.

[14]  J. Ortonne,et al.  Herlitz junctional epidermolysis bullosa keratinocytes display heterogeneous defects of nicein/kalinin gene expression. , 1994, The Journal of clinical investigation.

[15]  K. Stephens,et al.  A keratin 14 mutational hot spot for epidermolysis bullosa simplex, Dowling-Meara: implications for diagnosis. , 1993, The Journal of investigative dermatology.

[16]  S. Bale,et al.  Mutations in the H1 and 1A domains in the keratin 1 gene in epidermolytic hyperkeratosis. , 1994, The Journal of investigative dermatology.

[17]  D. Roop,et al.  Prenatal diagnosis of epidermolytic hyperkeratosis by direct gene sequencing. , 1994, The Journal of investigative dermatology.

[18]  E. Lane,et al.  Mutations in the rod 1A domain of keratins 1 and 10 in bullous congenital ichthyosiform erythroderma (BCIE). , 1994, The Journal of investigative dermatology.

[19]  D. Hohl,et al.  A mutational hot spot in keratin 10 (KRT 10) in patients with epidermolytic hyperkeratosis. , 1993, Human molecular genetics.

[20]  J. Bonifas,et al.  A novel three-nucleotide deletion in the helix 2B region of keratin 14 in epidermolysis bullosa simples: δE375 , 1993 .

[21]  I. Leigh,et al.  Missing links: Weber–Cockayne keratin mutations implicate the L12 linker domain in effective cytoskeleton function , 1993, Nature Genetics.

[22]  Y. Barrandon,et al.  A homozygous insertion–deletion in the type VII collagen gene (COL7A1) in Hallopeau–Siemens dystrophic epidermolysis bullosa , 1993, Nature Genetics.

[23]  E. Fuchs,et al.  The genetic basis of Weber-Cockayne epidermolysis bullosa simplex. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  H. Baribault,et al.  Mid-gestational lethality in mice lacking keratin 8. , 1993, Genes & development.

[25]  D. Cooper,et al.  Human Gene Mutation , 1993 .

[26]  J. Julien,et al.  Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis , 1993, Cell.

[27]  L. Cork,et al.  Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease , 1993, Cell.

[28]  Y. Barrandon,et al.  A missense mutation in the rod domain of keratin 14 associated with recessive epidermolysis bullosa simplex , 1993, Nature Genetics.

[29]  D. Parry,et al.  Keratin intermediate filament structure. Crosslinking studies yield quantitative information on molecular dimensions and mechanism of assembly. , 1993, Journal of molecular biology.

[30]  D. Parry,et al.  The conserved H1 domain of the type II keratin 1 chain plays an essential role in the alignment of nearest neighbor molecules in mouse and human keratin 1/keratin 10 intermediate filaments at the two- to four-molecule level of structure. , 1993, The Journal of biological chemistry.

[31]  J. Uitto,et al.  Identification of a leucine‐to‐proline mutation in the keratin 5 gene in a family with the generalized Köbner type of epidermolysis bullosa simplex , 1993, Human mutation.

[32]  F. Mansergh,et al.  A mutation (met→arg) in the type I keratin (K14) gene responsible for autosomal dominant epidermolysis bullosa simplex , 1993, Human mutation.

[33]  Elaine Fuchs,et al.  The genetic basis of epidermolytic hyperkeratosis: A disorder of differentiation-specific epidermal keratin genes , 1992, Cell.

[34]  S. Bale,et al.  A leucine→proline mutation in the H1 subdomain of keratin 1 causes epidermolytic hyperkeratosis , 1992, Cell.

[35]  S. Kubicka,et al.  Characterization of human cytokeratin 2, an epidermal cytoskeletal protein synthesized late during differentiation. , 1992, Experimental cell research.

[36]  D Hohl,et al.  Mutations in the Rod Domains of Keratins 1 and 10 in Epidermolytic Hyperkeratosis , 1992, Science.

[37]  D. Ward,et al.  In situ hybridization to the crithidia fasciculata kinetoplast reveals two antipodal sites involved in kinetoplast DNA replication , 1992, Cell.

[38]  E. Fuchs,et al.  Transgenic mice expressing a mutant keratin 10 gene reveal the likely genetic basis for epidermolytic hyperkeratosis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[39]  E. Lane,et al.  Selective involvement of keratins K1 and K10 in the cytoskeletal abnormality of epidermolytic hyperkeratosis (bullous congenital ichthyosiform erythroderma). , 1992, The Journal of investigative dermatology.

[40]  E. Lane,et al.  A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering , 1992, Nature.

[41]  E. Lane,et al.  Epidermolysis bullosa simplex (Dowling-Meara type) is a genetic disease characterized by an abnormal keratin-filament network involving keratins K5 and K14. , 1991, The Journal of investigative dermatology.

[42]  Alana L. Rothman,et al.  Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities. , 1991, Science.

[43]  Elaine Fuchs,et al.  Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: Genetic and functional analyses , 1991, Cell.

[44]  E. Fuchs,et al.  Mutant keratin expression in transgenic mice causes marked abnormalities resembling a human genetic skin disease , 1991, Cell.

[45]  E. Fuchs,et al.  Expression of mutant keratin cDNAs in epithelial cells reveals possible mechanisms for initiation and assembly of intermediate filaments , 1989, The Journal of cell biology.